Literature DB >> 10483606

Implementing a multiple-isolator unit for centralized preparation of cytotoxic drugs in a cancer center pharmacy.

J L Cazin1, P Gosselin.   

Abstract

Due to numerous reasons: assuring safety (technicians, patients, nurses, environment), preventing medication errors, cost, maintaining pharmaceutical quality, rules and regulations, it was decided to create a dedicated room within the pharmacy for the preparation of intravenous cytotoxic drugs. After a preliminary study, the following choices were made: isolator unit instead of a vertical laminar air-flow hood, rigid surface instead of flexible film, a multiple-unit structure (one half suit unit for storage and one isolator unit for passthrough, two preparation units, each with four double-gloving portals) instead of a single-unit structure. After the equipment was installed, the physical and microbiological processes were validated and a medical/pharmaceutical catalog of protocols was created. Then the technicians were trained and the standard operating procedures were written. Updated every six months, they describe the general organization, gaseous sterilization of the isolators, the drugs and the medical devices, prescription analysis and circuit, preparation of nominative forms and labels, double checking the preparations delivery, cleaning and maintenance, documentation and reports, waste disposal, safety and protection and instructions for emergency. The pharmacists, pharmacy staff, physicians and nurses were all included in a work group responsible for the isolator unit project. The unit was opened in January 1997.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10483606     DOI: 10.1023/a:1008731406552

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  10 in total

Review 1.  The risks of handling cytotoxic drugs. II. Recommendations for working with cytotoxic drugs.

Authors:  G P Kaijser; W J Underberg; J H Beijnen
Journal:  Pharm Weekbl Sci       Date:  1990-12-14

2.  Preventing medication errors in cancer chemotherapy.

Authors:  M R Cohen; R W Anderson; R M Attilio; L Green; R J Muller; J M Pruemer
Journal:  Am J Health Syst Pharm       Date:  1996-04-01       Impact factor: 2.637

Review 3.  ASHP technical assistance bulletin on handling cytotoxic and hazardous drugs.

Authors: 
Journal:  Am J Hosp Pharm       Date:  1990-05

Review 4.  Update on safe handling of hazardous drugs: the advice of experts.

Authors:  L A Power; R W Anderson; R Cortopassi; J R Gera; R M Lewis
Journal:  Am J Hosp Pharm       Date:  1990-05

5.  Hospital accreditation in France.

Authors:  J M Simon; C Segouin; D Bertrand
Journal:  Am J Health Syst Pharm       Date:  1998-01-15       Impact factor: 2.637

6.  Quality-improvement processes in an oncology pharmacy service.

Authors:  M C Lunik; B G Peters; A L Wilson
Journal:  Am J Health Syst Pharm       Date:  1996-04-01       Impact factor: 2.637

7.  Preventing chemotherapy errors.

Authors:  R J Ignoffo
Journal:  Am J Health Syst Pharm       Date:  1996-04-01       Impact factor: 2.637

8.  Standardizing the expression and nomenclature of cancer treatment regimens. American Society of Health-System Pharmacist (ASHP), American Medical Association (AMA), American Nurses Association (ANA).

Authors:  D R Kohler; M J Montello; L Green; C Huntley; J L High; A Fallavollita; B R Goldspiel
Journal:  Am J Health Syst Pharm       Date:  1998-01-15       Impact factor: 2.637

9.  What constitutes good prescribing?

Authors:  N Barber
Journal:  BMJ       Date:  1995-04-08

10.  Preparing cytotoxic agents in an isolator.

Authors:  M Favier; S Hansel; F Bressolle
Journal:  Am J Hosp Pharm       Date:  1993-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.